search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
CASE STUDY  ALMAC PHARMA SERVICES


Marion 4200L (148 ft³) Double-Cone Blender x 2 – sets the industry standard for batch mixing with minimal maintenance. Tumble blending offers rapid, low-impact mixing for high-precision blends.


The newer systems were designed to meet the latest standards for ATEX, CE and Pharma Good Manufacturing Practice (GMP), ensuring compliance with stringent safety and quality regulations. Additionally, the control systems were extensively redesigned to include audit trail monitoring and data integrity assurance, critical for maintaining rigorous pharmaceutical manufacturing standards. The systems also required integration into the site-wide single log-on (LDAP) system and additional process routes to accommodate potential new products under development. Furthermore, it was recommended that a new powder discharge assist system be included.


INSTALLATION AND COMMISSIONING PROCESS The installation and commissioning process was well planned and executed, beginning with a thorough site assessment and logistics coordination. Any installation issues were promptly resolved, resulting in the successful commissioning of the  it was fully operational and ready for use.


EQUIPMENT PERFORMANCE AND BUSINESS BENEFITS Equipment Performance – the newly installed blending equipment has demonstrated exceptional  performance aspects include: Reliability – the equipment operates consistently without unexpected downtimes, ensuring continuous production cycles. This reliability is crucial for maintaining uninterrupted operations and meeting production schedules. Effectiveness – the blending equipment effectively  mixing of materials to achieve uniform consistency. This ensures high-quality output that meets the stringent standards of Almac Pharma Services and its clients.


Advanced technology – the equipment incorporates advanced blending technology,  include high-throughput centrifugal screening and continuous scalping, while Marion blenders feature  gentle, uniform mixing and easy maintenance. Ease of use – user-friendly interfaces and controls make the equipment easy to operate, reducing the likelihood of human error and increasing overall productivity. Maintenance – the equipment is designed for easy maintenance, with accessible components and straightforward maintenance procedures, minimising downtime for repairs and servicing.


38 August 2024 Irish Manufacturing


 the installation of the new   Increased blending capacity – the primary advantage of the new equipment is its increased capacity, allowing Almac Pharma Services to blend larger volumes of materials in a shorter timeframe. This scalability is vital for meeting the growing demands of its expanding client base.  the advanced technology and reliability of the equipment enhance overall  times for client orders and the ability to handle more projects simultaneously. Quality assurance – the precise and consistent  meet high-quality standards. This quality assurance strengthens Almac Pharma Services’ reputation for delivering reliable and superior solutions to its global customers. Timely deliveries – with increased capacity and  deadlines more effectively, ensuring timely delivery of products. This reliability in meeting deadlines is a critical factor in maintaining and expanding client relationships. Cost savings – the reliable performance and ease of maintenance of the new equipment reduce operational costs associated with downtimes and repairs. Additionally, the increased capacity can lead to economies of scale, further lowering production costs.


Competitive advantage – the ability to meet higher demands and deliver quality products promptly gives Almac Pharma Services a competitive edge in the market. This positions the company as a preferred supplier in the industry, capable of handling large-scale and complex projects.


FUTURE PLANS Almac Pharma Services has established a strong working relationship with AMP, largely characterised by regular communication with a designated project manager, responsiveness in addressing maintenance requirements and resolving any issues. Looking ahead, Almac Pharma Services plans to


continue working with AMP for future equipment and supply needs. As Almac Pharma Services continues to expand and meet ongoing client demands, the proven reliability and performance of AMP’s equipment make them a preferred partner for future investments.


SUMMARY The partnership between Almac Pharma Services and AMP demonstrates a successful collaboration  future growth.


Through this case study, it is clear that Almac


Pharma Services’ strategic choice of equipment providers and its commitment to quality and  leading outsourcing partner in the pharmaceutical and biotechnology industry.


www.irish-manufacturing.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44